Abstract

It has been postulated that imprinting aberrations are common in tumors. To understand the role of imprinting in cancer, we have characterized copy-number and methylation in over 280 cancer cell lines and confirm our observations in primary tumors. Imprinted differentially methylated regions (DMRs) regulate parent-of-origin monoallelic expression of neighboring transcripts in cis. Unlike single-copy CpG islands that may be prone to hypermethylation, imprinted DMRs can either loose or gain methylation during tumorigenesis. Here, we show that methylation profiles at imprinted DMRs often not represent genuine epigenetic changes but simply the accumulation of underlying copy-number aberrations (CNAs), which is independent of the genome methylation state inferred from cancer susceptible loci. Our results reveal that CNAs also influence allelic expression as loci with copy-number neutral loss-of-heterozygosity or amplifications may be expressed from the appropriate parental chromosomes, which is indicative of maintained imprinting, although not observed as a single expression foci by RNA FISH.

Details

Title
Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors
Author
Martin-Trujillo, Alex 1 ; Vidal, Enrique 2   VIAFID ORCID Logo  ; Ana Monteagudo-Sánchez 1 ; Sanchez-Delgado, Marta 1   VIAFID ORCID Logo  ; Moran, Sebastian 3   VIAFID ORCID Logo  ; Jose Ramon Hernandez Mora 1 ; Heyn, Holger 4 ; Guitart, Miriam 5 ; Esteller, Manel 6 ; Monk, David 1 

 Imprinting and Cancer group, Cancer Epigenetic and Biology Program (PEBC), Institut d’Investigació Biomedica de Bellvitge (IDIBELL), Avinguda Granvia, L’Hospitalet de Llobregat, Barcelona, Spain 
 Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain 
 Cancer Epigenetics group, Cancer Epigenetic and Biology Program (PEBC), Institut d’Investigació Biomedica de Bellvitge (IDIBELL), Avinguda Granvia, L’Hospitalet de Llobregat, Barcelona, Spain 
 Universitat Pompeu Fabra (UPF), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain 
 Genetics Laboratory, UDIAT- Diagnostic Centre, Corporació Sanitària Parc Taulí, Sabadell, Spain 
 Cancer Epigenetics group, Cancer Epigenetic and Biology Program (PEBC), Institut d’Investigació Biomedica de Bellvitge (IDIBELL), Avinguda Granvia, L’Hospitalet de Llobregat, Barcelona, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain 
Pages
1-12
Publication year
2017
Publication date
Sep 2017
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1936521009
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.